IMVT
Immunovant, Inc. · Healthcare
Director Atul Pande sold $65K of Immunovant, Inc.
Sold$64,905
$43.27Price
1,500Shares
−1%Stake
What IMVT did after the filing
- The stock from Mon, Aug 31 open, $40.96
- −29.9%
- S&P 500, same days
- +1.4%
Measured over 30 trading days, to the Oct 13 close.
Traded Fri, Aug 28. Filed Fri, Aug 28, 4:27 PM ET, after the close. Returns use the Aug 31 open and the Oct 13 close. Not investment advice.